NCORP Clinical Trials Opened in February 2015
Posted: March 6, 2015
Two new clinical trials have opened to recruitment in February within the NCORP network.
ECOG-ACRIN E4112 is a prospective study of magnetic resonance imagine (MRI) and multi-parameter gene expression assay in ductal carcinoma in situ (DCIS). The trial was activated on February 17, 2015. For more information, read the press release from ECOG-ACRIN (PDF).
NRG-CC02 is a trial to assess if comprehensive patient questionnaires can help to predict complications in older patients with gynecologic cancer undergoing surgery. The trial was activated on February 10, 2015.
More information and access to both trials are available through the Cancer Trials Support Unit (CTSU).